Skip to main content

Cooper Companies Value Stock - Dividend - Research Selection

Cooper Companies, Inc. (The)

ISIN: US2166484020, WKN: 867409

Market price date: 21.07.2021
Market price: 401,50 USD




Cooper Companies, Inc. (The) Fundamental data and company key figures of the share

Annual reports in USD
Key figures 19-12-2020
Cash flow
Net operating cash flow 486.600.000
Capital Expenditures -310.400.000
Free cash flow 176.200.000
Balance sheet
Total Equity 3.824.600.000
Liabilities & Shareholders equity 6.737.500.000
Income statement
Net income 238.400.000
Eps (diluted) 4,810
Diluted shares outstanding 49.563.400
Net sales/revenue 2.430.900.000

Fundamental ratios calculated on: 21-07-2021

Ratios
Key figures 21-07-2021
Cash flow
P/C 40,90
   
P/FC 112,94
Balance sheet
ROI3,54
ROE56,77
Income statement
P/E83,47
Div. Yield0,02%
P/B5,20
P/S8,19


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolCOO
Market Capitalization19.899.705.344,00 USD
Country
IndicesS&P 500
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split2002-11-26,2.0000/1.0000; 2002-11-25,2.0000/1.0000; 1995-09-23,1.0000/3.0000; 1995-09-22,1.0000/3.0000; 1983-09-26,100.0000/110.0000
Internetwww.coopercos.com


Description of the company

The Cooper Companies, Inc. (Cooper, we or the Company), a Delaware corporation organized in 1980, is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life CompanyTM.. Cooper operates through two business units, CooperVision and CooperSurgical.

 

CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues; with a broad collection of spherical, toric and multifocal contact lenses. CooperVision's contact lenses are offered in a variety of materials including silicone hydrogel Aquaform® technology and phosphorylcholine technology (PC) Technology™. CooperVision primarily manufactures its products at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and the United States. CooperVision distributes products out of its facilities in the United States, the United Kingdom, Belgium and various smaller international distribution facilities.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.coopercos.com